BC001

BC001 · Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BC001, covering 2025-03-10 to 2025-03-10. Get the full timeline:

Most recent: Clinical Trial Update: BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma. [Phase 1]

See pricing